The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2023

Filed:

Jul. 25, 2018
Applicant:

Howard University, Washington, DC (US);

Inventors:

Oladapo Bakare, Silver Spring, MD (US);

Samuel Ray Denmeade, Ellicott City, MD (US);

Emmanuel S. Akinboye, Columbia, MD (US);

Assignee:

HOWARD UNIVERSITY, Washington, DC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); C07D 455/08 (2006.01); C07D 401/06 (2006.01);
U.S. Cl.
CPC ...
C07D 455/08 (2013.01); C07D 401/06 (2013.01); C07K 7/06 (2013.01);
Abstract

Compounds are provided herein which are emetine derivatives that can be used as prodrugs which selectively undergo activation to release emetine in specific cellular conditions. In one aspect, a blocking group is incorporated onto the emetine molecule by the derivization of the N2'-position with moieties that can be selectively removed by hydrolysis in the cancer/tumor microenvironment. Such compounds are less cytotoxic than emetine and are substantially inactive in non-cancerous cells. In one aspect, the compounds described herein can be used for the treatment of metastatic and non-metastatic cancers, including, for example, breast cancer, prostate cancer, lung cancer, and leukemia.


Find Patent Forward Citations

Loading…